TAVI Beneficial in Severe Aortic Stenosis

Myocardial function and exercise capacity improve in surviving patients

FRIDAY, April 13 (HealthDay News) -- While all-cause mortality is high in low-flow, low-gradient aortic stenosis patients receiving transcatheter aortic valve implantation (TAVI), surviving patients show significant improvements, according to a study published in the April issue of Catheterization & Cardiovascular Interventions.

Michael Gotzmann, M.D., from the BG University-Hospital Bergmannsheil in Bochum, Germany, and colleagues studied 167 consecutive patients with native severe aortic stenosis and an excessive operative risk who underwent TAVI. Of these, 15 patients presented with low-flow, low-gradient aortic stenosis (aortic valve area <1 cm², left ventricular (LV) ejection fraction <40 percent, aortic mean gradient <40 mm Hg). The CoreValve prosthesis 18-F-generation (Medtronic) was inserted retrograde. Six months following the procedure, clinical follow-up and echocardiography were performed.

The researchers found that patients with low-flow, low-gradient aortic stenosis (mean LV ejection fraction 32 ± 6 percent and a mean aortic gradient 27 ± 7 mm Hg) had significantly higher all-cause mortality six months after TAVI compared to patients without low-flow, low-gradient aortic stenosis (33 versus 13 percent). In the surviving 10 patients with low-flow, low-gradient aortic stenosis, LV ejection fraction significantly increased (34 ± 6 percent before versus 46 ± 11 percent six months after TAVI) and the patient covered significantly more distance in the six-minute walk test (218 ± 102 meters before versus 288 ± 129 meters six months after TAVI).

"Our study suggests that TAVI is feasible in patients with severe comorbidities and low-flow, low-gradient aortic stenosis," the authors write.

One author is a physician proctor for CoreValve (Medtronic).

Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events